BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program

– Expanding intellectual property estate expected to help drive ThermoStem® licensing opportunities – Previously published peer-reviewed preclinical data from a study conducted in collaboration with the University of Utah School of Medicine ("UUSOM") demonstrated a clonogenic population of metabolically active brown adipose tissue ("BAT") stem cells residing in adult humans that: (i) can be expanded in vitro; (ii) exhibit multilineage differentiation potential (osteogenetic, chondrogenic and adipogenic); an ...